On this week’s BioTech Nation, upping the game for wearables – NOAH KONIG from Cambridge Cognition and BEN FEHNERT from The CTRL Group, talk about their new venture, Cognition Kit. Measuring cognition along with the impact of medications, and opening up these measurements for others to develop applications.
On this week’s BioTech Nation, GEORGE YEH, the President of Taiwan-based TLC Biotherapeutics, tells us about their efforts to make treatments for Aged-related Macular Degeneration last longer, and Dr. CHUCK SHERWOOD, President & CEO of Anika Therapeutics, on how Anika is bringing three Osteoarthritis treatments, approved in Europe, to the US market.
On this week’s BioTech Nation, DR. DANIEL KRAFT, the Chair of Medicine at Singularity University. He’s the Founder of Exponential Medicine, the annual fall conference each year in San Diego, which brings together people interested in the frontiers of medicine, and the technology that can drive it.
On this week’s BioTech Nation, the second installment in our two-part series on Women in biotech venture capital. It’s WENDE HUTTON, NINA KJELLSON and JULIE PAPANEK, all from Canaan Partners.
On this week’s BioTech Nation, the winner of BIO’s Future Maker 2016 Award - Dr. HOWARD JACOBS from the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama.
On this week’s BioTech Nation, looking for new drugs … in the ocean. DR. EDUARDO ESQUENAZI, the Founder and CEO of Sirenas Marine Discovery, talks about bioprospecting.
BioTech Nation broadcasts from the International Biotechnology Conference, BIO 2016 in San Francisco. This week’s guests are JIM GREENWOOD, President and CEO of BIO, the Biotechnology Innovation Organization, MIKE MAY, Editorial Director, Scientific American WorldView 2016, and YALI FRIEDMAN, its head of Data Analytics, ROGER CRYSTAL, the CEO of Opiant Pharmaceuticals, and GARETH WILLIAMS with Marks & Clerk International Intellectual Property Firm.
On Biotech Nation with Dr Moira Gunn, how much do we know about the clinical trials behind drugs approved by the FDA? JENNIFER MILLER, the Founder and President of Bioethics, International and a professor at NYU Medical School, talks about the Good Pharma Scorecard.